SUN bioscience SA

Standardized cultures of stem cell-derived organoids, which are self-organizing 3D miniature tissues with organ-mimicking functions. The technology opens the door to personalized medicine, which means more effective treatments and fewer side effects than the current “one drug fits all” principle.SUN bioscience launched a clinical pilot to determine the efficacy of available medications on intestinal organoids grown from patients suffering from Cystic Fibrosis.